Skip to content

"Effect of Adipose Tissue-Derived Stem Cells Compared to PRP on Endometrial Thickness and Pregnancy Outcome in Women with Endometrial Hypotrophy"

Comparison of the Effect of Adipose Tissue-Derived Stem Cells Versus PRP on the Outcome of Embryo Transfer by FET Method in Patients with Endometrial Hypotrophy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
IRCT
Registry ID
IRCT20250202064611N1
Enrollment
20
Registered
2025-03-01
Start date
2025-02-18
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Hypotrophy. Noninflammatory disorder of uterus, unspecified

Interventions

Intervention 1: intervention group: Group 1 (ADSCs Group): Participants will receive intrauterine injections of autologous adipose-derived stem cells (ADSCs) obtained via minimal liposuction. The inje

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women aged 25 to 45 years. Diagnosis of endometrial hypotrophy (endometrial thickness =7mm). Candidates for frozen embryo transfer (FET). No history of endometrial cancer or severe uterine abnormalities. Willingness to provide informed consent for participation.

Exclusion criteria

Exclusion criteria: Presence of untreated uterine pathology (e.g., fibroids, polyps, adenomyosis). Known allergy or hypersensitivity to stem cell therapy or PRP. Severe systemic diseases or conditions contraindicating pregnancy. Participation in another clinical trial involving reproductive interventions. Patients who fail to adhere to study protocols or follow-ups

Design outcomes

Primary

MeasureTime frame
Endometrial thickness (measured in mm) before and after the intervention. Timepoint: Day 10 to 12 of the embryo transfer cycle (FET): Endometrial thickness (ET) assessmentIf ET = 7 mm (endometrial hypotrophy is confirmed): Administration of ADSCs or PRP48 hours after intervention: Re-evaluation of endometrial thickness. Method of measurement: Transvaginal ultrasound (TVUS) will be used to measure endometrial thickness.

Secondary

MeasureTime frame
Secondary outcomes include clinical pregnancy rate, implantation rate, biochemical pregnancy rate, and miscarriage rate.Comparison of ADSCs and PRP in improving endometrial receptivity and reducing miscarriage risk. Timepoint: on day 14 post-FET.Miscarriage assessment will be done throughout the first trimester. Method of measurement: Ultrasound assessment for implantation and endometrial receptivity.Serum ß-hCG levels for biochemical pregnancy detection.Follow-up of pregnancy viability and miscarriage confirmation by ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactfahimeh karimi

Shahid Beheshti University of Medical Sciences

karimimohanna8017@gmail.com+98 911 271 5409

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026